Hugon, G.; Goutal, S.; Dauba, A.; Breuil, L.; Larrat, B.; Winkeler, A.; Novell, A.; Tournier, N.
[18F]2-Fluoro-2-deoxy-sorbitol PET Imaging for Quantitative Monitoring of Enhanced Blood-Brain Barrier Permeability Induced by Focused Ultrasound. Pharmaceutics 2021, 13, 1752.
https://doi.org/10.3390/pharmaceutics13111752
AMA Style
Hugon G, Goutal S, Dauba A, Breuil L, Larrat B, Winkeler A, Novell A, Tournier N.
[18F]2-Fluoro-2-deoxy-sorbitol PET Imaging for Quantitative Monitoring of Enhanced Blood-Brain Barrier Permeability Induced by Focused Ultrasound. Pharmaceutics. 2021; 13(11):1752.
https://doi.org/10.3390/pharmaceutics13111752
Chicago/Turabian Style
Hugon, Gaëlle, Sébastien Goutal, Ambre Dauba, Louise Breuil, Benoit Larrat, Alexandra Winkeler, Anthony Novell, and Nicolas Tournier.
2021. "[18F]2-Fluoro-2-deoxy-sorbitol PET Imaging for Quantitative Monitoring of Enhanced Blood-Brain Barrier Permeability Induced by Focused Ultrasound" Pharmaceutics 13, no. 11: 1752.
https://doi.org/10.3390/pharmaceutics13111752
APA Style
Hugon, G., Goutal, S., Dauba, A., Breuil, L., Larrat, B., Winkeler, A., Novell, A., & Tournier, N.
(2021). [18F]2-Fluoro-2-deoxy-sorbitol PET Imaging for Quantitative Monitoring of Enhanced Blood-Brain Barrier Permeability Induced by Focused Ultrasound. Pharmaceutics, 13(11), 1752.
https://doi.org/10.3390/pharmaceutics13111752